Who owns IMMUNEERING CORP - CLASS A?

Tip: Access positions for across all investors

Analyze quarterly positions in Immuneering Corp - Class A with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Immuneering Corp - Class A stock

Who bought or sold IMMUNEERING CORP - CLASS A this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Cormorant Asset Management 3.3M $9.5M -22% Mar 2024
 View chart
Citadel Advisors 1.9M $5.4M -9% Mar 2024
 View chart
BlackRock 1.4M $4.0M -45% Mar 2024
 View chart
Vanguard Group 1.2M $3.5M 12% Mar 2024
 View chart
T. Rowe Price Associates 910k $2.6M -73% Mar 2024
 View chart
Geode Capital Management 463k $1.3M 7% Mar 2024
 View chart
Goldman Sachs Group 454k $1.3M -1% Mar 2024
 View chart
HighVista Strategies 255k $736k 0% Mar 2024
 View chart
FMR 233k $674k -62% Mar 2024
 View chart
Northern Trust 176k $509k -5% Mar 2024
 View chart
TD Asset Management 151k $436k -24% Mar 2024
 View chart
Bridgeway Capital Management 114k $330k 192% Mar 2024
 View chart
Exchange Traded Concepts 98k $284k 464% Mar 2024
 View chart
Millennium Management 63k $183k 453% Mar 2024
 View chart
Charles Schwab Investment Management 61k $175k 0% Mar 2024
 View chart
Bank of New York Mellon 54k $155k -16% Mar 2024
 View chart
Adage Capital Partners GP 50k $145k -74% Mar 2024
 View chart
Morgan Stanley 46k $132k 114% Mar 2024
 View chart
Nuveen Asset Management 44k $127k 9% Mar 2024
 View chart
CI Private Wealth 43k $125k 48% Mar 2024
 View chart
First Manhattan 33k $96k 100% Mar 2024
 View chart
Dimensional Fund Advisors 31k $91k 88% Mar 2024
 View chart
UBS Group 29k $84k 100% Mar 2024
 View chart
Corton Capital 27k $77k -2% Mar 2024
 View chart
Barclays 26k $75k -26% Mar 2024
 View chart
XTX Topco 25k $72k 100% Mar 2024
 View chart
Rhumbline Advisers 21k $61k 5% Mar 2024
 View chart
Pnc Financial Services 20k $58k 0% Mar 2024
 View chart
Janney Montgomery Scott 16k $46k -20% Mar 2024
 View chart
Jane Street 13k $39k 100% Mar 2024
 View chart
Bank of America Corporation 13k $38k -47% Mar 2024
 View chart
American Century Companies 12k $33k 1% Mar 2024
 View chart
Deutsche Bank Aktiengesellschaft 11k $33k -4% Mar 2024
 View chart
MetLife Investment Advisors 11k $83k 0% Dec 2023
 View chart
Oracle Alpha 11k $32k -5% Mar 2024
 View chart
American International 11k $82k 0% Dec 2023
 View chart
New York State Common Retirement Fund 9.7k $28k 6% Mar 2024
 View chart
Jpmorgan Chase & Co 9.3k $27k -42% Mar 2024
 View chart
Wells Fargo & Company 7.0k $20k 15% Mar 2024
 View chart
Citigroup 5.5k $16k 46% Mar 2024
 View chart
Tower Research Capital 4.9k $14k 51% Mar 2024
 View chart
California State Teachers Retirement System 2.5k $7.3k -49% Mar 2024
 View chart
Legal & General Group 2.2k $6.3k 0% Mar 2024
 View chart
Summit Investment Advisors 1.7k $4.8k 0% Mar 2024
 View chart
Metropolitan Life Insurance Company 1.2k $8.6k 0% Dec 2023
 View chart
Advisor Group Holdings 1.0k $2.9k 100% Mar 2024
 View chart
Royal Bank of Canada 784.00 $2.8k -89% Mar 2024
 View chart
Amalgamated Bank 684.00 $2.0k -74% Mar 2024
 View chart
Harbour Investments 25.00 $184.000000 0% Dec 2023
 View chart
Nelson, Van Denburg & Campbell Wealth Management 4.00 $11.000000 100% Mar 2024
 View chart
CWM 2.00 $0 100% Mar 2024
 View chart

Who sold out of Immuneering Corp - Class A?

Fund or Company Name Date Sold Shares Held Valued At
ExodusPoint Capital Management Sep 2023 121k $928k
HighTower Advisors Dec 2023 24k $176k
Virtu Financial Dec 2023 11k $84k
Mirae Asset Global Investments Dec 2023 11k $82k
Federated Investors Sep 2023 75.00 $576.000000